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Executive Summary
In recent years, the use of Medicare-covered home health care and
hospice services has grown dramatically. Hospice care, like much
home health and nonacute hospital care, is designed to meet the
needs of dying patients, who are known to generate disproportion-
ately large costs of care. How has use of these services by dying
Medicare beneficiaries changed over time? How has it varied by dis-
ease? Does recent experience suggest that these services have helped
save the Medicare program money by displacing hospital care and
other costly services? To address these questions, we examined
linked Medicare claims files from 1988 to 1995, determining the loca-
tion of death, days of use of services, and expenditures for the care of
beneficiaries in the final months of life.
We found that use of hospice and home health services by dece-
dents grew rapidly over the eight-year study period, and especially
rapidly among patients who died with a predictably terminal illness
such as lung cancer. Among the elderly who have such illnesses,
these alternatives to acute hospital care have reduced the use of hos-
pital care near the very end of life. Most of the growth in theseserv-
ices in the year or two before death, however, appears to involve
additional Medicare-covered services. As a result, utilization of
Medicare-covered home health and hospice care by dying beneficia-
ries has increased over time, with an associated reduction in the pro-
portion of deaths occurring in acute-care hospitals. But as the use
of nonhospital services has grown, the growth in Medicareex-
penditures for hospital services at the end of life has not slowed
appreciably, nor has there been a marked changethe intensity of73 Garber, MaCurdy, and McClellan
end-of-life treatment for Medicare beneficiaries dying of more acute
illnesses or requiring substantial supportive care.
I.Introduction
Discussions of the high level and rate of growth of Medicare expen-
ditures often focus on expenditures for the care of beneficiaries who
are nearing the end of life. Medicarerecipients typically use medical
services heavily as the time of death nears: historically,Medicare
recipients in their final year of life generated about sixtimes
the expenditures of the average surviving Medicare enrolleeand
accounted for almost 30 percent of total program spending (Lubitz
and Riley 1993). The use of health care accelerates rapidly duringthe
final months of life, leading many observers to infer that someof the
care provided is futile andmight be avoided or replaced by more
appropriate end-of-life care (Bayer, Callahan et al. 1983; Lubitz and
Prthoda 1984; Scitovsky 1984; Scitovsky 1988; Lubitz and Riley 1993;
Schneiderman and Jecker 1993; Emanuel and Emanuel 1994; Scitov-
sky 1994).
When a patient's illness is expected to end in death, the goalsof
health care can be shifted away from prolonging lifevia aggressive,
expensive, and sometimes painful interventions such as major oper-
ations and intensive caretoward comfort and relief of suffering.
The hallmarks of care targeted to the needs of dying patientsinclude
de-emphasis or elimination of the intensive treatments that accom-
pany acute hospitalization,and an emphasis on pain control and
other measures to improve the quality of the final stage of life.Such
care is offered by both inpatient andoutpatient hospice, and is often
a feature of home health services.Hospice and home health care
became more popular during the past decade, as Medicarebenefits
for these services became more widely available.
Home health care, in particular, was used more widely for the
elderly who were severely ill, along with those who had more lim-
ited acute or subacute health problems. The home health benefit was
intended to obviate or diminish the need for hospitalization among
the elderly with acute health problems, but Medicare recipientswho
had chronic diseases also used it heavily. Home health care received
after acute hospitalization has been eligible for reimbursement since
the beginning of the Medicare program, but two key developmentsMedical Care at the End of Life 79
in Medicare reimbursement have led to its much more widespread
use today.
The first was the implementation of the Prospective Payment Sys-
tem (PPS) for hospitalizations in 1984. Under PPS, hospitals received
fixed payments per hospital admission, adjusted for the diagnosis-
related group (DRG) that characterized the admission. Since pro-
longation of a hospital stay raised the hospital's costs but not its
revenues, PPS made it more attractive for hospitals to use alternatives
to hospitalization, such as home health care, for their patients who
did not need the full range of acute hospital services but were not
well enough to return home. Because home care was not considered
a cost of hospitalization covered under the fixed per-case reimburse-
ment, hospitals gained financially when they discharged patients to
home care rather than prolonging their hospital stays.
A second change was implemented in 1989, in the wake of a 1988
Federal district court decision (Duggan v. Bowen) that the Health Care
Financing Administration's interpretation of the home health benefit
had been too restrictive. The revised Medicare Home Health Agency
Manual clarified coverage criteria and resulted in expanded coverage
(Vladeck and Miller 1994). These regulatory changes were soon fol-
lowed by rapid growth in the supply of home health services (often
provided by for-profit home health agencies), and rapid growth in
the use of the Medicare home health benefit. Between 1988 and 1994,
the percentage of Medicare expenditures attributable to home health
care rose from 2.4 percent to 7.9 percent; between 1989 and 1992, the
number of visits per beneficiary nearly doubled, from twenty-seven
to fifty-three (Vladeck and Miller 1994). Alleged abuses of the home
health benefit led the Office of the Inspector General of the Depart-
ment of Health and Human Services to audit home health care and
issue regulations designed to detect and deter fraud and abuse.
The principal cause of this growth, according to some observers, is
the absence of disincentives to use home health care: home health
services are now essentially free to beneficiaries. But it is possible
that growth in the use of home health care has had offsetting effects
on the use of inpatient hospital services. Because their functional sta-
tus often declines as part of the illnesses preceding death, Medicare
beneficiaries near death may be particularly affected by the home
health care expansions. In particular, if patients have been better able
to make use of these services, in place of acute hospital services that
are also likely to be "free" to them, Medicare expenditure growth80 Garber, MaCurdy, and McClellan
near death may have moderated as a result. Thus the policy change
may have supported an important shift in nature and cost of health
care for the dying.
The relatively broad coverage of home health services contrasts
with stricter regulation of hospice care. Medicare rules state that a
beneficiary may become eligible for hospice care, which is generally
delivered in the home, when his or her life expectancy falls to six or
fewer months. Since 1992, hospice care has been subject to stricter
determinations of reimbursement eligibility than home health care,
although reimbursement rates for hospice care are generally higher.
One reason for this greater regulatory rigor may be the apparently
objective nature of the limit on the benefit: instead of a potentially
nebulous coverage rule, such as "all necessary services," hospice
coverage is time based. Life expectancy is not the same as actual
length of life. But if payment is often challenged for patients receiv-
ing care for much longer than six months, then physicians and hos-
pices might be reluctant to enroll patients in hospice until near the
very end of life. Of course, many hospice services can be provided
under the home health benefit, so providers can avoid such regula-
tory challenges, but less favorable reimbursement might be a strong
deterrent to substitution of home health for hospice care.
In this chapter, we explore the consequences of these changes in
Medicare utilization for care near the end of life. How have ex-
panded hospice and home health benefits altered end-of-life care for
Medicare recipients? We examine patterns of utilization of Medicare-
financed services in various periods before death, both for Medi-
care decedents generally and for those who have specific common
diseases, such as cancers and acute. myocardial infarction (heart
attack). We seek to learn whether Medicare recipients who died in
the 1990s used home health care and hospice services more heavily
than earlier cohorts of decedents, and whether the growth in use of
home health care services was greater among decedents than among
surviving Medicare recipients. We examine both the location of
death and the number of days that these services were used during
various periods before death. We discuss whether increases in such
services substituted for hospital care, or whether these enhanced
services simply added to the total utilization of Medicare-covered
services. Our analyses draw on comprehensive data for a large ran-
dom sample of Medicare recipients.Medical Care at the End of Life 81
II.Data
We compiled longitudinal summary data from all Medicare claims
for a 20 percent random sample of Medicare beneficiaries from 1988
through 1995. We excluded Medicare recipients less than sixty-five
years of age or more than ninety-nine years of age, those who resided
outside the United States, and those who were enrolled in health
maintenance organizations (primarily under capitated agreements).
We excluded Medicare "risk" enrollees, because detailed claims in-
formation was not available for them. Because they comprised a small
fraction of all enrollees during the period of study, their exclusion
appears to have had little effect on our results.
The resulting analytic sample consisted of almost 300,000 elderly
decedents for each of the eight years. We measured their utilization
of the following specific categories of services: acute care hospital;
home health care; nonacute care hospital; outpatient hospital ser-
vices; home hospice; inpatient hospice. We also measured Medicare
expenditures, including both acute and nonacute Medicare-covered
hospital admissions and hospice care (all covered under Part A,
Medicare's hospital benefit program) and home health expenditures
(mainly covered under Part A), as well as outpatient hospital care,
physician services, and other supplies (all covered under Part B, the
component of Medicare largely responsible for outpatient services).1
We considered two principal measures of each of these types of
expenditures: actual Medicare program expenditures (Medicare re-
imbursement) for the care of beneficiaries, and total expenditures for
these services, inclusive of patient payments. Thus total expenditures
included the beneficiary's liabilities due to copayments, deductibles,
and maximum limits on Medicare payments. Expenditures for serv-
ices not covered by Medicare at all, such as outpatient prescription
drugs, were not included.2 For the most part, beneficiary payments
(copayments and deductibles) tracked Medicare reimbursements
closely. In the results presented here, we focus primarily on Medicare
program payments; results for total reimbursement and patient pay-
ments were similar
To calculate expenditures for specific periods of time, we added
together Medicare expenditures for all valid claims during the period
in question. We converted all costs into 1995 dollars using the gross
domestic product (GDP) deflator.82 Garber, MaCurdy, and McClellan
We also sought to determine which kinds of services Medicare
recipients were using at the time of their deaths. Many decedents
died in a readily identifiable location. The location might have been
revealed, for example, by a date of death corresponding to the dis-
charge date from an acute or nonacute care hospital or nursing home,
or the end date for an outpatient service such as outpatient hospice
or home health care. If no other claims identifying a precise location
of death were available, but a patient was receiving hospice or home
health care in the last thirty days of life, we assigned the patient's
location of death accordingly. If no claims were recorded during the
final month of life, the beneficiary was assumed to have died at
home without services, or in a long-term care facility not covered by
Medicare.
Because we expected trends to vary with the underlying disease or
cause of death, we assigned to each decedent a disease category,
based on the 72-category diagnostic classification developed by the
National Center for Health Statistics for reporting mortality infor-
mation. We assigned diagnoses based on the inpatient (from the
MEDPAR files) or outpatient diagnoses preceding death; claims for
such services existed for about 60 percent of decedents. The disease is
classified according to the primary diagnosis recorded during the last
year of life that accounted for the largest share of beneficiary spend-
ing. This diagnosis is likely to be the health condition responsible for
the most utilization during the final year of life.
Before performing our analyses, we carried out simple tests to de-
termine whether our Medicare sample was representative of elderly
American decedents generally. We compared age-adjusted mortality
rates for the U.S. Vital Statistics series as compiled by the National
Center for Health Statistics with rates that we calculated from the
Medicare files. Discrepancies could arise primarily from omissions of
deaths or coding errors. We found that the age-adjusted mortality
rates were nearly identical.
Furthermore, the demographic characteristics of decedents were
essentially the same in both sources of data: 7 percent to 8 percent
of decedents were men sixty-five to seventy-four years of age, 16
percent-17 percent were men seventy-five to eighty-four years of
age, and 35 percent were men eighty-five or more years of age.
Women sixty-five to seventy-four years of age accounted for 4 per-
cent of deaths; those at age seventy-five to eighty-four accounted for
10 percent of deaths; and those eighty-five and more years of ageMedical Care a the End of Life 83
accounted for 28 percent of deaths, in both data sets in 1988. These
proportions remained relatively constant through 1995.
III.Results
Our results indicate that the growth in utilization of nonhospital ser-
vices among decedents was significant, whether measured by changes
in the location of death, days of use of the services, or expenditures.
Location of Death
Most beneficiaries use Medicare-covered services shortly before they
die, and these health services often define the location of death.
Many Americans die in acute care hospitals, others in nursing homes,
and still others without services covered by Medicare. Here we use
the term "location" to include both the physical place at which the
individual died and the category of services being received. The
location of a person who died while receiving no current services is
classified as "home," although many of these beneficiaries undoubt-
edly died in nursing homes. Other locations are "acute care hospi-
tal," "nursing home," "home health care" (resided at home while
receiving home health services), "nonacute care hospital," "hospital
outpatient," "hospice at home," and "hospice in hospital."
Figure 4.la shows the distribution of location of death for Medi-
care recipients between 1988 and 1995. During this period, the per-
centage of Medicare recipients who died in an acute care hospital fell
from about 42 percent to less than 35 percent. The percentage who
died without any Medicare-covered services fell much more dramat-
ically, from about 40 percent in 1988 to about 25 percent in 1995.
Most of the drop occurred between 1988 and 1989, but the trend con-
tinued in later years. Although rates of deaths in several other loca-
tions changed little, the percentage of enrollees dying while receiving
home health care rose sharply between 1988 and 1989, from nearly
none to about 6 percent. Between 1989 and 1995, hospice (both inpa-
tient and outpatient) became a much more common site of death; the
fraction of decedents enrolled in hospice rose from about 2 percent to
more than 10 percent. Thus, growth in the use of bothhospice and
home health care exceeded the drop in the percentages of benefi-
ciaries who died at home without services and of those who died
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Figure 4.la
Trends in location of death, 1988-1995
Disease-Specific Trends
For patients dying of chronic or subacute diseases, death is often
expected and the process of dying extends over weeks to months.
Such patients have greater opportunities to use services for the dy-
ing, such as hospice and home health care. Patients who die sud-
denly or unexpectedly are far less likely to use such services. Acute
myocardial infarction (AMI) is perhaps the most common example
of an acute condition that often causes rapid death in the elderly.
Although AMI can occur as a complication of an operation or illness,
and although it often occurs in men and women who are known to
have heart disease, the event is usually sudden and unexpected, fre-
quently causing death soon after the initial hospital admission for
treatment, if not before admission can occur. Although survivors of
AMI may die much later from complications of the heart attack, the
cause of death may be recorded as the complication of AMI (such as
an unstable heart rhythm or weakening of the heart muscle sufficient
to cause severe congestive heart failure) rather than AMI itself. Thus
AMI survivors are neither typical users of hospice care nor are they
particularly likely to die while receiving home health care.
Thus the major finding shown in figure 4.lblittle change in the
location of death for Medicare recipients who died with a diagnosis1988 1989 1990 1991 1992 1993 1994 1995
Figure 4.lb
Trends in location of death from AMI, 1988-1995
of AMI during the period of studyis unsurprising. Hemorrhagic
stroke, another disorder that is often quickly fatal, displays a similar
pattern (figure 4.lc): about 70 percent of deaths occurred in an acute
care hospital. Between 1988 and 1995 there was an increase in the
fraction of deaths that occurred in nonacute care hospitals. Other-
wise, however, there was no discernible trend in the location of
death.
In contrast, lung cancer is a prototypical terminal illness, for which
the imminence if not the exact timing of death is more predictable.
For individuals who have advanced disease, it is nearly always the
cause of death. The predictability of death means that decisions
about care prior to death can be made more deliberately, unlike those
for a patient who has an acute condition. Thus lung cancer and other
advanced cancers are typical of conditions that routinely lead to hos-
pice care, affording a choice between hospitalization and alternative
services that is unavailable for many other conditions. The growth in
utilization of hospice care is reflected in the location of death for lung
cancer patients, as shown in figure 4.ld. Accompanying a decline
from 52 percent to 36 percent in the fraction of lung cancer deaths
that occurred in hospitals was a dramatic increase in the fraction of
beneficiaries who died while receiving outpatient hospice. In 1988,
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Figure 4.le
Trends in location of death from COPD, 1988-1995
ficiary was receiving hospice care; by 1995, the fraction was 30 per-
cent. Between 1988 and 1989 there was a large drop, from 33 percent
to 17 percent, in the fraction of lung cancer patients dying at home
without services; by 1995, only about 10 percent of Medicare dece-
dents with lung cancer died without Medicare-covered services.
Chronic obstructive pulmonary disease (COPD) is a category of
respiratory illness that includes chronic bronchitis, emphysema, and
some forms of asthma. Its severity is highly variable, causing symp-
toms ranging from mildly annoying to severely disabling. Even
patients whose COPD is severe enough to require oxygen supple-
mentation and frequent hospitalizations can survive for years. Fur-
thermore, although utilization of medical services can be heavy
before death, individuals who have COPD may not suffer from the
severe pain that often accompanies advanced cancer. Consequently,
COPD patients may be less likely than lung cancer patients to enter a
hospital or seek hospice care before death. As figure 4.le shows, a
little over 35 percent of COPD deaths occurred in hospitals in 1995,
with no change from 1988. These data contrast with the 70 percent
rates of hospital death for AMI and hemorrhagic stroke. Like lung
cancer deaths, COPD deaths were much less likely to occur at home
without services in 1995 than in 1988. The fraction of deaths at home
fell from 43 percent to less than 22 percent by 1995, with the largest
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Hospital Hospice Days













1988 1995 1988 1995 1999 1995 1998 1995
0-30 Days Before Death 31-90 Days Before Death 91-365 Days Before Deafh366-730 Days Betere Death
Figure 4.2a
Trends in monthly Medicare utilization near death, 1988-1995
patients who died while receiving home care rose from about 1 per-
cent to 8 percent; by 1995, it reached 10 percent. The fraction who
died while receiving inpatient or outpatient hospice care or nonacute
hospital care also grew, from about 3 percent in 1988 to more than 10
percent in 1995.
Trends in Utilization
Defined on the basis of services used at the time of death, the
location of death serves as a crude proxy for utilization during the
month before death. We now turn to direct measures of utilization,
asking two questions: how extensively did Medicare recipients use
various Medicare-covered services during several time periods pre-
ceding death? What were the trends in utilization between 1988 and
1995? Figure 4.2a displays overall monthly utilization and trends in
monthly utilization for 1 to 30 days before death, 31 to 90 days before
death, 91 to 365 days before death, and 366 to 730 days before death,
for each of the years of observation. The measures of utilization are
days in acute hospital, nonacute hospital, intensive care/coronary
care unit (ICU/CCU), and home and inpatient (hospital) hospice.14
12
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Figure 4.2b
Trends in monthly Medicare utilization near death from AMI,1988-1995
As figure 4.2a makes clear, the number of days on which at least
one service was provided rose sharply as the date of death neared.
Within the final period before death, the number of days of utiliza-
tion overall increased between 1988 and 1995. There was little change
in ICU/CCU days, but acute hospital days fell over time, and both
hospice and nonacute hospital days increased. The trends are most
evident during the month preceding death, but in the two months
prior and, to a lesser extent, the entire year preceding death, it is
clear that hospice and nonacute hospital services were used much
more heavily in 1995 than in 1988. Between nine and ten of the final
thirty days of life were spent either in a hospital or using one of the
other services, whereas fewer than two of the last thirty days were
spent in an ICU/CCU.
Trends in disease-specific utilization correspond closely to the
trends in location of death. Utilization of services before death
among patients who had AMI, the most acute of the conditions
examined here, changed little over time (figure 4.2b). Days of ICU/
CCU care were greater than for the other diagnoses, as expected, but
there was little increase in the other categories of service over time,































Trends in monthly Medicare utilization near death from hemorrhagic stroke, 1988-
1995
number of ICU/CCU days actually declined over time for Medicare
recipients with hemorrhagic stroke (figure 4.2c), as did acute hospital
days. For this diagnosis, overall utilization fell with time, although
there was a sharp rise in nonacute hospital days in 1989. Utilization
of home hospice and of hospital-based hospice rose substantially
between 1988 and 1995 for patients who had lung cancer, especially
in the month before death (figure 4.2d). Although the number of
acute hospital days in the final month of life fell from about nine in
1988 to six in 1995, the rise in hospice days and days of other services
more than offset this decline, so that the total days of service utiliza-
tion rose from about eleven to fourteen between 1988 and 1995. Sim-
ilar but less striking trends are evident for COPD (figure 4.2e).
Expenditures
The most direct evidence of substitution of services comes from
expenditure data. Utilization data do not provide direct information
about the total costs of care, and it is possible that a rise in home
health services, for example, can directly reduce the use of hospital-
izations. Furthermore, since each home health visit is less expensive
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Figure 4.2d
Trends in monthly Medicare utilization near death from lung cancer, 1988-1995
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Figure 4.3a
Trends in monthly Medicare expenditures near death, 1988-1995
than a typical acute hospital day, a reduction in hospital days, even if
accompanied by a larger rise in the number of days of home health
care, may reduce overall expenditures. To understand the impli-
cations of the utilization trends for Medicare expenditures, we
looked at trends in category-specific and overall Medicare expendi-
tures for decedents. The expenditure calculations include physicians'
services. Because we do not measure expenditures for services
that Medicare does not cover, such as prescription drugs and ex-
tended nursing home stays (or stays in nursing homes that are not
Medicare-qualified), our results reflect programmatic rather than all-
source medical expenditures.
As figure 4.3a shows, per-decedent total expenditures in the final
month of life rose from about $5,400 in 1988 to $7,400 in 1995,
expressed in 1995 dollars. Similar, albeit weaker, trends are evident
in the other periods preceding the final month. Expenditures in the
final month of life for inpatient and outpatient hospice care, along
with expenditures for home health care, more than doubled during
the interval. Because they were the largest component of health
expenditures, hospital expenditures accounted for much of the over-
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Figure 4.3b
Trends in monthly Medicare expenditures near death from AMI, 1988-1995
of growth of hospital inpatient expenditures in the final month of life
was 4.7 percent, despite the rapid growth in use of other services.
As figure 4.3b shows, expenditures in the final month of life for
decedents who had AMI rose sharply, especially in the 1990s. Be-
tween 1988 and 1995, hospital expenditures, which accounted for
most of the health care expenditures during the final month of life,
rose by nearly 50 percent in real terms, to $10,000. For earlier inter-
vals before death, such as the period from one year to ninety-one
days before death and from two years to one year before death, the
major trend was an increase in utilization of outpatient services. For
example, the average beneficiary who died in 1988 with AMI had
$235 in outpatient Medicare expenditures during the period from
two years to one year before death. By 1995, the comparable figure
had risen to $707.
Hemorrhagic stroke (figure 4.3c) exhibits similar trends. As we saw
before, most deaths from this cause occur in the hospital, as is
reflected in the high and rising proportion of acute hospital expendi-
tures in the final month of life. Unlike beneficiaries who die with
AMI, decedents who have hemorrhagic stroke have modest expendi-
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Figure 4.3c
Trends in monthly Medicare expenditures near death from hemorrhagic stroke, 1988-
1995
perhaps because hemorrhagic strokes often occur in individuals
who do not have chronic illnesses. Many patients who died from
AMI, in contrast, would have received medical care for previous
AMI and other symptoms of coronary artery disease for many years
before they died.
Lung cancer decedents (figure 4.3d) had sharply rising expendi-
tures for nonacute hospital care and for inpatient and outpatient hos-
pice. Inpatient expenditures during the final month of life actually
declined in real terms between 1988 and 1990 but began a gradual
rise in 1990 that accelerated by 1994, despite growing expenditures
for nonacute hospital care and hospice care. Expenditures for COPD
decedents (figure 4.3e) were generally lower in the month before
death than were those for AMI and hemorrhagic stroke decedents.
Another way to appreciate trends is to compare expenditures for
specific services near the time of death to expenditures for all Medi-
care recipients for the same services. Those ratios, as shown in figure
4.4, demonstrate that relative expenditures changed little over the
period of study. Hospice is a unique category because the benefit is
limited to those Medicare recipients who are expected to live for no
more than six months. Accurate estimation of the prognosis would
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Figure 4.3d
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Figure 4.3e































































Ratio of expenditures in last year of life to overall expenditures,1988-1995
imply that all hospice expenditures are in the last year of life; the
actual ratio is about 14 to 1. Relative use of outpatient care and acute
hospital care has increased modestly since 1989, and the relative use
of other services has remained largely flat. Thus expenditures for
specific categories of services by decedents has grown at about the
overall rate of growth of expenditures for these services. The evi-
dence presented here suggests that the use of hospice and home
health care did not significantly reduce expenditures on other cate-
gories of care among decedents.
IV.Conclusions
Reflecting widespread sentiment that it should provide appropriate
care for beneficiaries at the end of their lives, reinforced by cost con-
siderations, the Medicare program has made it easier for seriously ill
recipients to gain access to alternatives to hospital care. The policy
changes, including liberalization of reimbursement practices for
alternatives to hospital care, apparently had the intended effect of
making such services more broadly available to dying Medicare
recipients. We found that use of these services grew throughout the
late 1980s and early 1990s, and that the use of hospice and similar
services designed for dying patients grew most rapidly among














1995: n=293,933Medical Care at the End of Life 97
care. However, most of the growth in hospice care occurred among
recipients in their final one to three months of life.
The longstanding recognition that medical expenditures rise before
death has fueled the speculation, and perhaps the hope, that greater
availability of less-intensive care targeted toward dying patients
would reduce expenditures at the end of life. For our sample of
Medicare decedents, whether analyzed by specific disease or more
generally, utilization of acute hospitals declined over time. The
simultaneous rise in the use of hospice and other services, however,
meant that the number of days that patients received Medicare-
covered services rose between 1988 and 1995. Although inpatient
care delivered in acute care hospitals is usually the most expensive
component of health services, the net effect of these changes in utili-
zation was an increase in monthly Medicare expenditures before
death, rising from about $5,500 in 1988 to more than $7,000 in 1995
(in 1995 dollars). Expenditures for dying Medicare recipients are
expected to rise in the coming decades as the baby boomers reach
advanced ages, producing a large cohort of elderly Americans. Our
results suggest that there has been no reduction in the growth of per
capita expenditures at the end of life, so total expenditures will grow
still more rapidly when demographic trends combine with rising per
capita expenditures.
Over long periods of time, according to other studies, the fraction
of Medicare expenditures attributable to Medicare recipients in the
final year of life has remained stable (Lubitz and Riley 1993). Our
results suggest that the increased adoption of putative substitutes for
acute hospital care, such as hospice, has not slowed the growth of
Medicare expenditures. However, adoption of such services might
have different effects in the future, with changes in the interpretation
of the hospice and home health benefits, changes in policies and
reimbursement for hospitalization, and the shift toward capitation.
The growing use of such services may be a salutary trend because
they improve the well-being and satisfaction of dying patients and
their families, but thus far there is little evidence that they will alle-
viate Medicare's financial challenges.
Notes
This research was supported in part by grants AG07651, AG11706, and ACO5842 from
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grant 26749 from the Robert Wood Johnson Foundation. We are grateful to Victoria
Stodden for excellent research assistance and to Joe Antos for helpful discussion.
We integrated information from the five major administrative data files maintained
by the Health Care Financing Administration: claims for hospital and skilled nursing
facility stays (MEDPAR, or Medical Provider Analysis and Review files), home health
care (HHA, or Home Health Agency), hospice care, outpatient visits, and physician
and supplier services.
The other major type of uncovered service is long-term stays in nursing homes.
Nursing home admissions after an acute-care admission are covered for the first 100
days, so that the vast majority of shorter nonacute hospital stays for the elderly are
now covered by Medicare.
References
Bayer, R., D. Callahan, et al. 1983. "The care of the terminally ill: mortality and eco-
nomics." New England Journal of Medicine 309:1490-4.
Emanuel, E., and L. Emanuel. 1994. "The economics of dying: the illusion of cost
savings at the end of life." New England Journal of Medicine 330(8):540-4.
Garber, A., and V. Fuchs. 1992. "Health expenditures for older Americans: 1990-2040."
Stanford University. Mimeo (unpublished).
Helbing, C. 1993. "Medicare program expenditures." Health Care Financing Review
(1992 annual supplement):23-54.
Lubitz, J., and R. Prihoda. 1984. "The use and costs of Medicare services in the last two
years of life." Health Care Financing Review 5:117-31.
Lubitz, J., and G. Riley. 1993. "Trends in Medicare payments in the last year of life."
New England Journal of Medicine 328(15):1092-6.
Schneiderman, L., and N. Jecker. 1993. "Futility in practice." Archives of Internal Medi-
cine 153:437-41.
Scitovsky, A. 1984. "The high cost of dying': what do the data show?" Milbank Memo-
rial Fund Quarterly/Health and Society 62:591-608.
Scitovsky, A. 1988. "Medical care in the last twelve months of life: the relation between
age, functional status, and medical care expenditures." Milbank Quarterly 66:640-60.
Scitovsky, A. A. 1994. "The high cost of dying' revisited." Milbank Quarterly 72(4):561-
591.
Verbrugge, L. 1984. "Longer life but worsening health? Trends in health and mortality
of middle-aged and older persons." Milbank Memorial Fund Quarterly 62:475-519.
Vladeck, B. C., and N. A. Miller. 1994. "The Medicare Home Health Initiative." Health
Care Financing Review 16(1):7-16.